Finance

Lists
RUA:NZE
Rua Bioscience Ltd
0,030 NZ$
0,00%
(0,00) 1D
16 қаз., 11:20:40 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for RUA...
Open
0,03 NZ$
High
0,03 NZ$
Low
0,03 NZ$
Mkt. cap
10,18 млн
Avg. vol.
84,61 мың
Volume
0,00
52-wk high
0,04 NZ$
52-wk low
0,02 NZ$
EPS
-0,01 NZ$
Shares outstanding
339,44 млн
No. of employees
13
Open
0,03 NZ$
High
0,03 NZ$
Low
0,03 NZ$
Mkt. cap
10,18 млн
Avg. vol.
84,61 мың
Volume
0,00
52-wk high
0,04 NZ$
52-wk low
0,02 NZ$
EPS
-0,01 NZ$
Shares outstanding
339,44 млн
No. of employees
13
News stories
From web sources and news partners
About Rua Bioscience Ltd
CEO-
Employees13
Founded2016
Headquarters-
SectorPharmaceutical industry
Websiteruabio.com
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
727,66 м.
727,66 м.
677,70 м.
677,70 м.
Cost of goods sold
450,40 м.
450,40 м.
429,84 м.
429,84 м.
Cost of revenue
450,40 м.
450,40 м.
429,84 м.
429,84 м.
Research and development expenses
263,44 м.
263,44 м.
175,35 м.
175,35 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1,10 млн
1,10 млн
998,60 м.
998,60 м.
Total operating expenses
1,55 млн
1,55 млн
1,43 млн
1,43 млн
Operating income
-818,40 м.
-818,40 м.
-750,74 м.
-750,74 м.
Other non operating income
-
-
-
-
EBT including unusual items
-896,72 м.
-896,72 м.
-783,12 м.
-783,12 м.
EBT excluding unusual items
-902,02 м.
-902,02 м.
-766,01 м.
-766,01 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
832,22 м.
832,22 м.
823,25 м.
823,25 м.
Net income
-896,72 м.
-896,72 м.
-783,12 м.
-783,12 м.
Net profit margin
-123,23%
-123,23%
-115,55%
-115,55%
Earnings per share
-
-
-
-
Interest and investment income
553,00
553,00
15,53 мың
15,53 мың
Interest expense
-84,17 мың
-84,17 мың
-74,30 мың
-74,30 мың
Net interest expenses
-83,62 мың
-83,62 мың
-58,77 мың
-58,77 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-733,69 м.
-733,69 м.
-666,03 м.
-651,58 м.
Gain or loss from assets sale
-
-
2,63 мың
2,63 мың
AI content may include mistakes. Learn more
Google қолданбалары